COSA's 45th Annual Scientific Meeting, 13 - 15 November 2018 Perth Convention and Exhibition Centre

Dr Mark Lee

Dr Mark Lee is a qualified radiation oncologist working at Liverpool Hospital in NSW. He completed an MSc at the University of Toronto on stereotactic body radiotherapy for liver cancer and has subspecialty interests in treating gastro-intestinal cancers and head and neck cancer. He has published original articles for highly conformal radiotherapy and has also been actively involved in research through his career. He is involved in several research projects within the institutions he has been working at, and has successfully co-supervised a PhD student investigating the role of MRI and FDG-PET in predicting outcomes for head and neck cancer. He is currently primary investigator for the quality assurance program of the international multi-centre trial run by the International Atomic Energy Agency trial E33036 “Randomized Phase III Clinical Trial of Stereotactic Body Radiation Therapy versus Transarterial Chemoembolization in Hepatocellular carcinoma). He is the lead investigator for several inhouse trials including a prospective stereotactic body radiotherapy trial for treatment of borderline resectable and locally advanced pancreatic cancer, 4D MRI imaging in upper gastro-intestinal cancer and functional MRI and PET imaging for mucosal head and neck cancer. Additionally he has had significant roles in education of radiation oncology registrars, working as the Director of Training for radiation oncology registrars from 2010 to 2012 at the Peter MacCallum Cancer Centre and is a current supervisor of trainees and research mentor.